Skip to Content
Stock Analyst Update

Boeing Raises and Conserves Cash in Second Quarter

We lower our fair value estimate for the company as it awaits its MAX re-entry and a better environment.

Mentioned:

Wide-moat-rated Boeing (BA) reported a pivotal quarter as the company adjusts its longer-term commercial production targets to better serve the smaller aviation market. We’re reducing our fair value estimate to $264 per share from $281 to reflect lower midcycle 737 MAX  and 787 production and consequently a lower midcycle operating margin due to less learning curve improvements. We remain bullish on the stock, and our critical assumption is that Boeing will return to 2018 narrow-body production levels by 2024, which is predicated on the assumed wide distribution of a COVID-19 vaccine by mid-2021.

Commercial revenue dropped 65% due to lower deliveries and lower predelivery payments, or PDPs. While the MAX has now been grounded for over a year, Boeing had still been receiving PDPs from numerous customers for MAX orders in 2019 and faced a far more accommodative wide-body market. Within the valuable narrow-body market, the 737 MAX remains grounded and the firm has lost roughly 7.5% of its unadjusted order book year to date, but the firm has made visible steps toward recertification. Particularly, Boeing has completed the MAX’s certification flight and the U.S. Federal Aviation Administration intends to open up a public comment period on the proposed rulemaking soon. We are slightly pushing back an assumption on an airworthiness directive to early fourth quarter, but we are encouraged by the visible progress toward recertification. A critical question remains if airlines will be able to take delivery of the aircraft. We’re assuming that a COVID-19 vaccine will be available by the end of 2020, which we think will be a critical sign for airlines to prepare for bringing capacity back. Boeing noted that roughly 4.25% of the global fleet has been grounded since the beginning of the pandemic, so airlines will need to take delivery of new aircraft to return to 2019 capacity.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Burkett Huey does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.